Sight Sciences [SGHT] vs Nevro [NVRO] Detailed Stock Comparison

Sight Sciences Inc.

NASDAQ
Loading...

Nevro Corp.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Sight Sciences Inc. wins in 6 metrics, Nevro Corp. wins in 11 metrics, with 0 ties. Nevro Corp. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sight Sciences Inc. Nevro Corp. Better
P/E Ratio (TTM) N/A 144.40 N/A
Price-to-Book Ratio 3.66 0.96 Nevro Corp.
Debt-to-Equity Ratio 63.77 108.86 Sight Sciences Inc.
PEG Ratio -7.85 -2.26 Nevro Corp.
EV/EBITDA -5.39 -2.15 Nevro Corp.
Profit Margin (TTM) -49.67% -27.77% Nevro Corp.
Operating Margin (TTM) -18.00% -21.79% Sight Sciences Inc.
Return on Equity -50.74% -43.29% Nevro Corp.
Return on Assets (TTM) -16.61% -9.95% Nevro Corp.
Free Cash Flow (TTM) $-29.92M $-29.23M Nevro Corp.
1-Year Return 31.71% -56.06% Sight Sciences Inc.
Price-to-Sales Ratio (TTM) 3.07 0.55 Nevro Corp.
Enterprise Value $182.12M $180.16M Sight Sciences Inc.
EV/Revenue Ratio 2.35 0.44 Nevro Corp.
Gross Profit Margin (TTM) 87.26% 62.45% Sight Sciences Inc.
Revenue per Share (TTM) $1 $11 Nevro Corp.
Earnings per Share (Diluted) $-0.74 $-3.06 Sight Sciences Inc.
Beta (Stock Volatility) 2.49 0.82 Nevro Corp.
Short % of Float 2.70% N/A N/A

Sight Sciences Inc. vs Nevro Corp. Stock Performance Analysis

Loading Price Chart...

SGHT
NVRO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sight Sciences Inc.0.00%-10.88%2.84%-17.49%-49.30%-41.98%
Nevro Corp.0.00%N/AN/AN/AN/AN/A

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sight Sciences Inc.31.71%-35.37%-85.14%-85.14%-85.14%-85.14%
Nevro Corp.-56.06%-92.38%-94.65%-89.12%-76.92%-76.92%

Performance & Financial Health Analysis: Sight Sciences Inc. vs Nevro Corp.

MetricSGHTNVRO
Market Information
Market Cap i$237.20M$224.09M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i460,0651,058,636
90 Day Avg. Volume i341,5851,147,389
Last Close$4.34$5.84
52 Week Range$3.11 - $9.24$3.16 - $13.84
% from 52W High-53.01%-57.80%
All-Time High$42.57 (Aug 02, 2021)$188.14 (Dec 21, 2020)
% from All-Time High-89.81%-96.90%
Growth Metrics
Quarterly Revenue Growth0.07%-0.09%
Quarterly Earnings Growth0.07%-0.09%
Financial Health
Profit Margin (TTM) i-0.50%-0.28%
Operating Margin (TTM) i-0.18%-0.22%
Return on Equity (TTM) i-0.51%-0.43%
Debt to Equity (MRQ) i63.77108.86
Cash & Liquidity
Book Value per Share (MRQ)$1.20$6.11
Cash per Share (MRQ)$1.70$7.72
Operating Cash Flow (TTM) i$-29,694,000$-19,439,000
Levered Free Cash Flow (TTM) i$-16,124,625$-4,766,875
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Sight Sciences Inc. vs Nevro Corp.

MetricSGHT (Apr 26, 2026)NVRO (May 17, 2025)
Price Ratios
P/E Ratio (TTM) iN/A144.40
Forward P/E i-7.85-2.26
PEG Ratio i-7.85-2.26
Price to Sales (TTM) i3.070.55
Price to Book (MRQ) i3.660.96
Market Capitalization
Market Capitalization i$237.20M$224.09M
Enterprise Value i$182.12M$180.16M
Enterprise Value Metrics
Enterprise to Revenue i2.350.44
Enterprise to EBITDA i-5.39-2.15
Risk & Other Metrics
Beta i2.490.82
Book Value per Share (MRQ) i$1.20$6.11

Financial Statements Comparison: Sight Sciences Inc. vs Nevro Corp.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSGHT (2025)NVRO (2024)
Revenue/Sales i77.36M408.52M
Cost of Goods Sold i10.70M138.99M
COGS % of Revenue i13.8%34.0%
Gross Profit i66.67M269.53M
Gross Margin i86.2%66.0%
Research & Development i14.61M51.51M
Operating Income (EBIT) i-37.10M-94.70M
Operating Margin i-48.0%-23.2%
EBITDA i-36.76M-67.70M
EBITDA Margin i-47.5%-16.6%
Pre-Tax Income i-38.42M-112.35M
Pre-Tax Income % of Revenue i-49.7%-27.5%
Income Tax i10,0001.09M
Income Tax % of Revenue i0.0%0.3%
Net Income (Profit) i-38.43M-113.44M
Profit Margin i-49.7%-27.8%

Balance Sheet & Liquidity Metrics

MetricSGHT (2025)NVRO (2024)
Cash & Equivalents i91.97M94.54M
Total Current Assets i112.73M476.00M
Total Current Assets % of Revenue i145.7%116.5%
Total Current Liabilities i11.03M102.94M
Total Current Liabilities % of Revenue i14.3%25.2%
Long-Term Debt i40.30M213.19M
Long-Term Debt % of Revenue i52.1%52.2%
Total Shareholders Equity i63.94M231.01M
Retained Earnings i-384.72M-812.85M
Retained Earnings % of Revenue i-497.3%-199.0%
Property, Plant & Equipment i2.65M36.77M

Cash Flow Statement Comparison

MetricSGHT (2025)NVRO (2024)
Operating Cash Flow i-24.47M-25.99M
Operating Cash Flow % of Revenue i-31.6%-6.4%
Capital Expenditures i-224,000-9.79M
Free Cash Flow i-29.92M-29.23M
FCF Margin i-38.7%-7.2%
Debt Repayment i00
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSGHTNVRO
Shares Short i1.07MN/A
Short Ratio i2.42N/A
Short % of Float i2.70%N/A
Shares Outstanding i53.49M37.82M
Float Shares i35.29M34.23M
% Held by Insiders i20.96%2.84%
% Held by Institutions i48.49%110.59%
% Held by Public i30.55%-13.43%

Dividend Analysis & Yield Comparison: Sight Sciences Inc. vs Nevro Corp.

MetricSGHTNVRO
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A